FDA NDC Directory · JSON-LD · Markdown

Levemir

NDC 0169-3687 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin detemir
Labeler / ManufacturerNovo Nordisk
Marketing categoryBiologic License Application · App BLA021536
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN DETEMIR (100 [iU]/mL)
Marketing started20060327
Marketing ended20260831
Package count1

External sources

Source: openFDA. Public-domain (CC0).